Curtiss-Wright holder plans Rule 144 sale of 418 shares

Curtiss-Wright Corporation has a shareholder filing a Rule 144 notice covering the planned sale of 418 shares of common stock, with an aggregate market value of 261,940.

Accepted by SEC EDGAR 02/04/2026 - 04:36 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Curtiss-Wright Corporation has a shareholder filing a Rule 144 notice covering the planned sale of 418 shares of common stock, with an aggregate market value of 261,940. The shares are to be sold through UBS Financial Services Inc. on the NYSE, with an approximate sale date of 02/04/2026. These 418 shares were acquired on 02/03/2026 through a performance stock vest from the issuer. Shares outstanding were 36,874,638 as of the figure provided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Curtiss-Wright (CW) Form 144 filing disclose?

The Form 144 shows a Curtiss-Wright shareholder plans to sell 418 common shares under Rule 144. The shares were recently acquired through a performance stock vest and are expected to be sold on the NYSE through UBS Financial Services Inc.

How many Curtiss-Wright (CW) shares are planned for sale under this Form 144?

The filing covers a proposed sale of 418 shares of Curtiss-Wright common stock. The aggregate market value of these shares is reported as 261,940, with trading expected on the NYSE through UBS Financial Services Inc. under Rule 144.

When were the Curtiss-Wright (CW) shares acquired and how?

The 418 Curtiss-Wright common shares were acquired on 02/03/2026 through a performance stock vest from the issuer. This indicates the shares came from equity compensation rather than an open-market cash purchase, immediately preceding the planned Rule 144 sale.

When is the Curtiss-Wright (CW) Rule 144 sale expected to occur?

The notice lists an approximate sale date of 02/04/2026 for the 418 Curtiss-Wright common shares. The transaction is to be executed on the NYSE through UBS Financial Services Inc., consistent with the resale framework allowed under SEC Rule 144.

What market value is reported for the Curtiss-Wright (CW) shares in this Form 144?

The Form 144 reports an aggregate market value of 261,940 for the 418 Curtiss-Wright common shares covered by the planned sale. This figure reflects the total value of the block indicated in the filing, to be sold on the NYSE under Rule 144.

How many Curtiss-Wright (CW) shares are outstanding according to the filing?

The notice lists 36,874,638 Curtiss-Wright common shares outstanding. This provides context for the planned Rule 144 sale of 418 shares, showing the sale relates to a very small portion of the total outstanding common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001836007
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Curtiss-Wright Corporation
SEC File Number	001-00134
Address of Issuer	130 Harbour Place Drive Suite 300 Davidson NORTH CAROLINA 28036
Phone	973-541-3753
Name of Person for Whose Account the Securities are To Be Sold	Robert Freda
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	418	261940	36874638	02/04/2026	nyse

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/03/2026	performance stock vest	issuer			418	02/03/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Robert Freda
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)